Clinical Trial Update: Barrett's Esophagus - 315 - 3 Way Cross-Over [Phase 4]

View source ↗

Summary

A Phase 4 three-way cross-over trial for Barrett's Esophagus sponsored by AstraZeneca has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barrett Esophagus

Snippet

Sponsor: AstraZeneca | Conditions: Barrett's Esophagus | Phase 4 | Status: COMPLETED